Literature DB >> 3778442

Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation.

H Yamada, T Yoshida, H Sakamoto, M Terada, T Sugimura.   

Abstract

A human pancreatic cancer cell line, PSN-1, was established from pancreatic adenocarcinoma tissue that had been stored for 1.5 years at -80 degrees C without any special treatment. The stored tissues were first transplanted into nude mice, and from the xenograft, the PSN-1 cell line was established. The original primary tumor and two metastatic lymph nodes were previously found to have 50-fold amplification of c-myc and also 3- to 6-fold amplification of activated c-Ki-ras with a point mutation from GGT to CGT at codon 12. PSN-1 cells are unique in that amplifications of both c-myc and activated c-Ki-ras are present in the same degree as the original tumors. These cells were also found to contain increased amounts of c-myc and c-Ki-ras transcripts.

Entities:  

Mesh:

Year:  1986        PMID: 3778442     DOI: 10.1016/0006-291x(86)91072-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.

Authors:  W J Krzyzosiak; N Shindo-Okada; H Teshima; K Nakajima; S Nishimura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.

Authors:  Liran Zhou; Hongmei Husted; Todd Moore; Mason Lu; Defeng Deng; Yan Liu; Vijaya Ramachandran; Thiruvengadam Arumugam; Christof Niehrs; Huamin Wang; Paul Chiao; Jianhua Ling; Michael A Curran; Anirban Maitra; Mien-Chie Hung; Jeffrey E Lee; Craig D Logsdon; Rosa F Hwang
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

3.  Down-regulation of focal adhesion kinase, pp125FAK, in endothelial cell retraction during tumor cell invasion.

Authors:  H Okamoto; S Nakamori; M Mukai; K Shinkai; H Ohigashi; O Ishikawa; H Furukawa; S Imaoka; Y Matumoto; M Monden; H Akedo
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

4.  Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.

Authors:  Christian Maasch; Axel Vater; Klaus Buchner; Werner G Purschke; Dirk Eulberg; Stefan Vonhoff; Sven Klussmann
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

5.  Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.

Authors:  T Oikawa; J Hitomi; A Kono; E Kaneko; K Yamaguchi
Journal:  Int J Pancreatol       Date:  1995-08

6.  Concurrent mutations in two different ras genes in acute myelocytic leukemias.

Authors:  J W Janssen; J Lyons; A C Steenvoorden; H Seliger; C R Bartram
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

7.  Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.

Authors:  N E Kohl; F R Wilson; S D Mosser; E Giuliani; S J deSolms; M W Conner; N J Anthony; W J Holtz; R P Gomez; T J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  Development of peritoneal tumor-targeting vector by in vivo screening with a random peptide-displaying adenovirus library.

Authors:  Takeshi Nishimoto; Yuki Yamamoto; Kimiko Yoshida; Naoko Goto; Shumpei Ohnami; Kazunori Aoki
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas.

Authors:  Saleh Al-Ghamdi; Abdulkader Albasri; Julien Cachat; Salih Ibrahem; Belal A Muhammad; Darryl Jackson; Abdolrahman S Nateri; Karin B Kindle; Mohammad Ilyas
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.

Authors:  J C Fox; J England; P White; G Ellison; K Callaghan; N R Charlesworth; J Hehir; T L McCarthy; J Smith-Ravin; I C Talbot; D Snary; J M Northover; C R Newton; S Little
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.